RecruitingNCT03882580

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

Sponsor

Groupe Hospitalier Pitie-Salpetriere

Enrollment

5,000 participants

Start Date

Mar 1, 2019

Study Type

OBSERVATIONAL

Conditions

Cardiovascular Complication Cardiac Complication Metabolic Disorder Oncologic Complications Vascular Disorder Cardiovascular Insufficiency Cardiac Insufficiency Cardiac Disorder

Summary

Several Drugs used in routine care in oncology induce rare but often severe or fatal cardiovascular or metabolic side effects. This study will investigate, evaluate, report and treat the cardiovascular side effects of anticancer drugs, through a specific cardiovascular routine checkup and follow-up taking place in several Cardio-oncology programs throughout France. The different including centers will be: Assistance Publique - Hôpitaux de Paris (APHP.6: Pitié-Salpétrière, Saint Antoine and Tenon's hospitals, Paris, France).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Anti-Cancer Agents for people with cardiac complication, cardiac disorder, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAnti-Cancer Agents

Drugs and treatments used in cancer inducing cardiovascular and metabolic side effects

Locations(3)

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM

Paris, France, France

AP-HP, Saint-Antoine Hospital, Department of cardiology

Paris, France

AP-HP, Tenon Hospital, Department of Cardiology

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03882580

Related Trials

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NCT0707518510 locations

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

NCT066898001 location

Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial

NCT055314741 location

Integrative Oncology for Patient Symptoms

NCT049407801 location

Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry

NCT032096741 location